GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $14.97 $17.43 Thursday, 18th Apr 2024 CPRX stock ended at $15.34. This is 4.13% less than the trading day before Wednesday, 17th Apr 2024. During the day the stock fluctuated 6.00% from a day low at $15.33 to a day high of $16.25.
90 days $13.12 $17.50
52 weeks $11.09 $17.77

Historical Catalyst Pharmaceuticals prices

Date Open High Low Close Volume
2023-12-29 $17.20 $17.22 $16.74 $16.81 788 311
2023-12-28 $17.30 $17.40 $16.96 $17.20 660 569
2023-12-27 $17.18 $17.32 $16.88 $17.29 952 410
2023-12-26 $16.66 $17.25 $16.60 $17.14 766 606
2023-12-22 $16.34 $16.82 $16.13 $16.58 1 163 684
2023-12-21 $14.96 $16.31 $14.88 $16.07 2 549 294
2023-12-20 $14.69 $14.84 $14.27 $14.30 904 000
2023-12-19 $14.20 $14.78 $14.20 $14.73 930 372
2023-12-18 $14.47 $14.47 $14.00 $14.10 1 009 562
2023-12-15 $14.53 $15.00 $14.21 $14.38 3 966 126
2023-12-14 $14.09 $14.57 $13.88 $14.49 1 562 174
2023-12-13 $13.30 $14.03 $13.27 $14.03 1 518 357
2023-12-12 $13.73 $13.73 $13.00 $13.35 1 666 638
2023-12-11 $14.11 $14.12 $13.71 $13.81 1 158 938
2023-12-08 $14.19 $14.43 $14.02 $14.15 1 123 676
2023-12-07 $14.01 $14.33 $13.86 $14.31 897 010
2023-12-06 $14.27 $14.39 $13.87 $14.01 992 016
2023-12-05 $14.83 $14.85 $14.07 $14.25 1 444 445
2023-12-04 $14.69 $15.07 $14.63 $15.06 1 037 453
2023-12-01 $14.46 $14.85 $14.35 $14.82 1 052 978
2023-11-30 $14.17 $14.51 $14.06 $14.43 1 114 185
2023-11-29 $14.29 $14.44 $14.03 $14.05 1 034 393
2023-11-28 $14.04 $14.28 $13.94 $14.21 689 823
2023-11-27 $13.97 $14.17 $13.77 $14.10 792 180
2023-11-24 $13.89 $14.09 $13.82 $14.06 410 644
Click to get the best stock tips daily for free!

About Catalyst Pharmaceuticals

Catalyst Pharmaceuticals Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); and Ruzurgi for the treatment of pediatric LEMS patients. The company also develop... CPRX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT